Key result
Coronary artery bypass grafting generally provides better long-term outcomes, including lower rates of repeat revascularization and improved survival in patients with diabetes or complex multivessel disease, compared to percutaneous coronary intervention.
Why the study?
What are the comparative outcomes of percutaneous coronary interventions versus coronary artery bypass surgery in patients with coronary artery disease?
What are the comparative outcomes of percutaneous coronary interventions versus coronary artery bypass surgery in patients with coronary artery disease?
A multidisciplinary heart team is crucial for selecting the optimal revascularization strategy (PCI vs CABG) for patients with coronary artery disease.
Supports heart team decisions for CAD revascularization; confirms benefits of modern PCI and CABG from recent RCTs.
The optimal revascularization strategy for patients with coronary artery disease is influenced by the continuous improvement in medical therapy and the improved designs of the new generation of coronary stents allowing them to be increasingly applied in patients with complex coronary anatomy, including those with left main stem disease. On the other hand, surgical results are also improved as a result of the increased experience over years and the improvement of myocardial protection techniques. This will make the comparison of percutaneous coronary interventions and coronary artery bypass surgery a moving target. In this paper, we reviewed the recent randomized controlled trials and important registries emphasizing the benefits and the results of each therapy in different patient subsets. A heart team of both cardiologists and cardiac surgeons is of paramount importance in choosing the optimal revascularization strategy.
No takes yet. Share an insight, caveat, or question.
Albacker et al. (2014) conducted a review in Coronary Artery Disease. Percutaneous Coronary Intervention (PCI) vs. Coronary Artery Bypass Grafting (CABG) was evaluated. Coronary artery bypass grafting generally provides better long-term outcomes, including lower rates of repeat revascularization and improved survival in patients with diabetes or complex multivessel disease, compared to percutaneous coronary intervention.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: